Girish S. Shroff
University of Texas MD Anderson Cancer Center
CancerInternal medicineRadiologyPET-CTSurgeryPathologyMagnetic resonance imagingOncologyTomographyIntensive care medicineAdverse effectLung cancerChemotherapyMesotheliomaImmunotherapyLungPericardiumDiseaseProton therapyMalignancyMEDLINEDifferential diagnosisTargeted therapyRadiographyRadiation therapyComputed tomographyMedicine
72Publications
9H-index
305Citations
Publications 71
Newest
#1Brett W. Carter (University of Texas MD Anderson Cancer Center)H-Index: 26
#2Mehmet Altan (University of Texas MD Anderson Cancer Center)H-Index: 18
Last. Ioannis Vlahos (University of Texas MD Anderson Cancer Center)H-Index: 1
view all 5 authors...
Non-small-cell lung cancer (NSCLC) is frequently diagnosed when it is not amenable to local therapies; therefore, systemic agents are the mainstay of therapy for many patients. In recent years, treatment of advanced NSCLC has evolved from a general approach primarily involving chemotherapy to a more personalised strategy in which biomarkers such as the presence of genomic tumour aberrations and the expression of immune proteins such as programmed death-ligand 1 (PD-L1), in combination with other...
Source
#1Jitesh Ahuja (University of Texas MD Anderson Cancer Center)H-Index: 7
#2P. de Groot (University of Texas MD Anderson Cancer Center)H-Index: 2
Last. Carol C. Wu (University of Texas MD Anderson Cancer Center)H-Index: 26
view all 8 authors...
Most of the complications following lung cancer surgery occur in the early postoperative period and can result in significant morbidity and mortality. Delayed complications can also occur. Diagnosing these complications can be challenging because clinical manifestations are non-specific. Imaging plays an important role in detecting these complications in a timely manner and facilitates prompt interventions. Hence, it is important to have knowledge of the expected anatomical alterations following...
Source
#1Nahyun Jo (University of Texas MD Anderson Cancer Center)
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Mylene T. Truong (University of Texas MD Anderson Cancer Center)H-Index: 42
view all 7 authors...
Abstract null null In the imaging of the mediastinum, benign lesions mimicking malignancy constitute potential pitfalls in interpretation. Localization and characteristic imaging features are key to narrow the differential diagnosis and avoid potential pitfalls in interpretation. Based on certain anatomic landmarks, the mediastinal compartment model enables accurate localization. Depending on the anatomic origin, mediastinal lesions can have various etiologies. The anatomic location and structur...
Source
#1Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
#2Chad D. Strange (University of Texas MD Anderson Cancer Center)H-Index: 1
Last. Ioannis Vlahos (University of Texas MD Anderson Cancer Center)H-Index: 1
view all 8 authors...
By boosting the immune system, immunotherapy with immune checkpoint inhibitors (ICIs) has altered the management of patients with various cancers including those with metastatic non-small cell lung cancer (NSCLC). As a result of immune system activation, ICIs are associated with unique response patterns (that are not addressed by traditional response criteria) and inflammatory side effects termed immune-related adverse events. In this article, we will review the role of immunotherapy in cancer t...
Source
#1Chad D. Strange (University of Texas MD Anderson Cancer Center)H-Index: 1
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Jeremy J. Erasmus (University of Texas MD Anderson Cancer Center)H-Index: 41
view all 6 authors...
Radiation therapy using conventional fractionated external-beam or high-precision dose techniques including three-dimensional conformal radiotherapy, stereotactic body radiation therapy, intensity-modulated radiation therapy, and proton therapy, is a key component in the treatment of patients with lung cancer. Knowledge of the radiation technique used, radiation treatment plan, expected temporal evolution of radiation-induced lung injury and patient-specific parameters, such as previous radiothe...
Source
#1Jitesh Ahuja (University of Texas MD Anderson Cancer Center)H-Index: 7
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Mylene T. Truong (University of Texas MD Anderson Cancer Center)H-Index: 42
view all 6 authors...
Abstract Most lung cancers are diagnosed at advanced stage when the cancer has metastasized outside the lung. These patients are not eligible for curative surgery or radiation therapy and treated with systemic therapy. Advances in the understanding of the biology of lung cancer has resulted in the development of targeted therapy aimed at specific genetic mutations identified with non-small cell lung cancer (NSCLC) and immunotherapy that helps the immune system recognize tumors as foreign, stimul...
Source
#1Chad D. Strange (University of Texas MD Anderson Cancer Center)H-Index: 1
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Eric M. Rohren (BCM: Baylor College of Medicine)H-Index: 40
view all 4 authors...
Abstract Whole body positron emission tomography (PET)/computed tomography (CT) imaging with [18F]-fluoro-2-deoxy-D-glucose (FDG) is widely used in oncologic imaging. In the chest, common PET/CT applications include the evaluation of solitary pulmonary nodules, cancer staging, assessment of response to therapy, and detection of residual or recurrent disease. Knowledge of the technical artifacts and potential pitfalls that radiologists may encounter in the interpretation of PET/CT in the thorax i...
Source
#1Chad D. Strange (University of Texas MD Anderson Cancer Center)H-Index: 1
#2Ioannis Vlahos (University of Texas MD Anderson Cancer Center)H-Index: 1
Last. Jane P. Ko (NYU: New York University)H-Index: 28
view all 7 authors...
Abstract A variety of surgical procedures are utilized to treat a spectrum of cardiopulmonary diseases. In the imaging of patients in the post-operative period, it is important to have an understanding of surgical techniques including invasive and minimally invasive procedures and the expected postsurgical findings. Knowledge of certain patient risk factors, various complications associated with specific surgical procedures, and a keen attention to detail are essential to avoid misinterpretation...
Source
#1Chad D. Strange (University of Texas MD Anderson Cancer Center)H-Index: 1
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Mylene T. Truong (University of Texas MD Anderson Cancer Center)H-Index: 42
view all 6 authors...
Abstract Malignant pleural mesothelioma is a rare tumor arising from the pleural mesothelial cells. Imaging plays a crucial role in the diagnosis, staging, and management of patients with mesothelioma. Accurate staging to stratify patients into homogeneous groups is required to evaluate the effectiveness of multimodality therapeutic regimens. CT and PET/CT are recommended for the initial staging of MPM. MRI adds value to further assess invasion of the tumor into the diaphragm, chest wall, and me...
Source
#1Melissa Carroll (KU: University of Kansas)H-Index: 1
#2Girish S. Shroff (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Christopher M. Walker (KU: University of Kansas)H-Index: 15
view all 4 authors...
Abstract Imaging plays an essential role in the diagnosis and staging of pulmonary malignancy. Familiarity of less common manifestations of lung cancer including subsolid nodule, consolidation, and cyst associated lung cancer is important to avoid delayed diagnosis and improve patient outcomes. In this article, we review the staging of multifocal lung cancer, PET negative lung cancers (carcinoid and indolent lung adenocarcinoma), and false positive lymph nodes on PET due to infectious and inflam...
Source